Colistin methanesulfonate sodium salt structure
|
Common Name | Colistin methanesulfonate sodium salt | ||
---|---|---|---|---|
CAS Number | 8068-28-8 | Molecular Weight | 1759.898 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C58H115N16Na5O28S5 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of Colistin methanesulfonate sodium saltColistin methanesulfonate sodium salt exhibits MIC values ranged from 4 to 16 mg/liter against susceptible strains (P. aeruginosa)[1]. |
Name | colistin methanesulfonate sodium salt |
---|---|
Synonym | More Synonyms |
Description | Colistin methanesulfonate sodium salt exhibits MIC values ranged from 4 to 16 mg/liter against susceptible strains (P. aeruginosa)[1]. |
---|---|
Related Catalog | |
In Vitro | Colistin methanesulfonate is less bactericidal than colistin at the same multiples of the MIC. Colistin and colistin methanesulfonate are both unequal mixtures of the salts of two components, colistins A and B (1), which may well have different in vitro activities[1]. |
References |
Molecular Formula | C58H115N16Na5O28S5 |
---|---|
Molecular Weight | 1759.898 |
Exact Mass | 1758.615845 |
Appearance of Characters | white to faintly beige |
Storage condition | 2-8°C |
Water Solubility | H2O: soluble10mg/mL |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | 3249 |
WGK Germany | 2 |
RTECS | GH1650000 |
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.
J. Chromatogr. A. 1369 , 52-63, (2014) Colistin is a last resort's antibacterial treatment in critically ill patients with multi-drug resistant Gram-negative infections. As appropriate colistin exposure is the key for maximizing efficacy w... |
|
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
PLoS ONE 10 , e0142097, (2015) Exacerbations associated with chronic lung infection with Pseudomonas aeruginosa are a major contributor to morbidity, mortality and premature death in cystic fibrosis. Such exacerbations are treated ... |
|
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Antimicrob. Agents Chemother. 45 , 781-785, (2001) The in vitro pharmacodynamic properties of colistin and colistin methanesulfonate were investigated by studying the MICs, time-kill kinetics, and postantibiotic effect (PAE) against mucoid and nonmuco... |
Colistrimethate sodium |
EINECS 232-516-9 |
MFCD00130824 |
Colimycin M |
Colistimethate sodium |
Sodium colistimethate |
Colistin sodium methanesulfonate |
Colistimethate |
Sodium methanesulfonate - N-[(2S)-4-amino-1-{[(2S,3R)-1-{[(2S)-4-amino-1-oxo-1-({(6S,9R,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-diisobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl}amino)-2-butanyl]amino}-3-hydroxy-1-oxo-2-butanyl]amino}-1-oxo-2-butanyl]-6-methyloctanamide (5:5:1) |